Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury

Standard

Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury. / Papakrivopoulou, Eugenia; Vasilopoulou, Elisavet; Lindenmeyer, Maja T; Pacheco, Sabrina; Brzóska, Hortensja Ł; Price, Karen L; Kolatsi-Joannou, Maria; White, Kathryn E; Henderson, Deborah J; Dean, Charlotte H; Cohen, Clemens D; Salama, Alan D; Woolf, Adrian S; Long, David A.

in: J PATHOL, Jahrgang 246, Nr. 4, 12.2018, S. 485-496.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Papakrivopoulou, E, Vasilopoulou, E, Lindenmeyer, MT, Pacheco, S, Brzóska, HŁ, Price, KL, Kolatsi-Joannou, M, White, KE, Henderson, DJ, Dean, CH, Cohen, CD, Salama, AD, Woolf, AS & Long, DA 2018, 'Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury', J PATHOL, Jg. 246, Nr. 4, S. 485-496. https://doi.org/10.1002/path.5158

APA

Papakrivopoulou, E., Vasilopoulou, E., Lindenmeyer, M. T., Pacheco, S., Brzóska, H. Ł., Price, K. L., Kolatsi-Joannou, M., White, K. E., Henderson, D. J., Dean, C. H., Cohen, C. D., Salama, A. D., Woolf, A. S., & Long, D. A. (2018). Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury. J PATHOL, 246(4), 485-496. https://doi.org/10.1002/path.5158

Vancouver

Bibtex

@article{bd2bd884abcc4957b41a66ba9342b648,
title = "Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury",
abstract = "Planar cell polarity (PCP) pathways control the orientation and alignment of epithelial cells within tissues. Van Gogh-like 2 (Vangl2) is a key PCP protein that is required for the normal differentiation of kidney glomeruli and tubules. Vangl2 has also been implicated in modifying the course of acquired glomerular disease, and here, we further explored how Vangl2 impacts on glomerular pathobiology in this context. Targeted genetic deletion of Vangl2 in mouse glomerular epithelial podocytes enhanced the severity of not only irreversible accelerated nephrotoxic nephritis but also lipopolysaccharide-induced reversible glomerular damage. In each proteinuric model, genetic deletion of Vangl2 in podocytes was associated with an increased ratio of active-MMP9 to inactive MMP9, an enzyme involved in tissue remodelling. In addition, by interrogating microarray data from two cohorts of renal patients, we report increased VANGL2 transcript levels in the glomeruli of individuals with focal segmental glomerulosclerosis, suggesting that the molecule may also be involved in certain human glomerular diseases. These observations support the conclusion that Vangl2 modulates glomerular injury, at least in part by acting as a brake on MMP9, a potentially harmful endogenous enzyme. {\textcopyright} 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.",
keywords = "Journal Article",
author = "Eugenia Papakrivopoulou and Elisavet Vasilopoulou and Lindenmeyer, {Maja T} and Sabrina Pacheco and Brz{\'o}ska, {Hortensja {\L}} and Price, {Karen L} and Maria Kolatsi-Joannou and White, {Kathryn E} and Henderson, {Deborah J} and Dean, {Charlotte H} and Cohen, {Clemens D} and Salama, {Alan D} and Woolf, {Adrian S} and Long, {David A}",
note = "{\textcopyright} 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.",
year = "2018",
month = dec,
doi = "10.1002/path.5158",
language = "English",
volume = "246",
pages = "485--496",
journal = "J PATHOL",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury

AU - Papakrivopoulou, Eugenia

AU - Vasilopoulou, Elisavet

AU - Lindenmeyer, Maja T

AU - Pacheco, Sabrina

AU - Brzóska, Hortensja Ł

AU - Price, Karen L

AU - Kolatsi-Joannou, Maria

AU - White, Kathryn E

AU - Henderson, Deborah J

AU - Dean, Charlotte H

AU - Cohen, Clemens D

AU - Salama, Alan D

AU - Woolf, Adrian S

AU - Long, David A

N1 - © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

PY - 2018/12

Y1 - 2018/12

N2 - Planar cell polarity (PCP) pathways control the orientation and alignment of epithelial cells within tissues. Van Gogh-like 2 (Vangl2) is a key PCP protein that is required for the normal differentiation of kidney glomeruli and tubules. Vangl2 has also been implicated in modifying the course of acquired glomerular disease, and here, we further explored how Vangl2 impacts on glomerular pathobiology in this context. Targeted genetic deletion of Vangl2 in mouse glomerular epithelial podocytes enhanced the severity of not only irreversible accelerated nephrotoxic nephritis but also lipopolysaccharide-induced reversible glomerular damage. In each proteinuric model, genetic deletion of Vangl2 in podocytes was associated with an increased ratio of active-MMP9 to inactive MMP9, an enzyme involved in tissue remodelling. In addition, by interrogating microarray data from two cohorts of renal patients, we report increased VANGL2 transcript levels in the glomeruli of individuals with focal segmental glomerulosclerosis, suggesting that the molecule may also be involved in certain human glomerular diseases. These observations support the conclusion that Vangl2 modulates glomerular injury, at least in part by acting as a brake on MMP9, a potentially harmful endogenous enzyme. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

AB - Planar cell polarity (PCP) pathways control the orientation and alignment of epithelial cells within tissues. Van Gogh-like 2 (Vangl2) is a key PCP protein that is required for the normal differentiation of kidney glomeruli and tubules. Vangl2 has also been implicated in modifying the course of acquired glomerular disease, and here, we further explored how Vangl2 impacts on glomerular pathobiology in this context. Targeted genetic deletion of Vangl2 in mouse glomerular epithelial podocytes enhanced the severity of not only irreversible accelerated nephrotoxic nephritis but also lipopolysaccharide-induced reversible glomerular damage. In each proteinuric model, genetic deletion of Vangl2 in podocytes was associated with an increased ratio of active-MMP9 to inactive MMP9, an enzyme involved in tissue remodelling. In addition, by interrogating microarray data from two cohorts of renal patients, we report increased VANGL2 transcript levels in the glomeruli of individuals with focal segmental glomerulosclerosis, suggesting that the molecule may also be involved in certain human glomerular diseases. These observations support the conclusion that Vangl2 modulates glomerular injury, at least in part by acting as a brake on MMP9, a potentially harmful endogenous enzyme. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

KW - Journal Article

U2 - 10.1002/path.5158

DO - 10.1002/path.5158

M3 - SCORING: Journal article

C2 - 30125361

VL - 246

SP - 485

EP - 496

JO - J PATHOL

JF - J PATHOL

SN - 0022-3417

IS - 4

ER -